GH Research (GHRS) Common Equity (2020 - 2025)
GH Research (GHRS) recorded quarterly Common Equity of $279.7 million in Q4 2025, up 56.3% quarter-over-quarter from $179.0 million in Q4 2024, and up 56.3% on a YoY basis from $179.0 million in Q4 2024.
GH Research (GHRS) Common Equity (2020 - 2025) Analysis & Trends
GH Research's Common Equity history runs 6 years deep, the most recent figure standing at $279.7 million for Q4 2025.
- In Q4 2025, Common Equity rose 56.3% year-over-year to $279.7 million; the TTM figure through Dec 2025 stood at $279.7 million (up 56.3% YoY), while the FY2025 annual figure was $279.7 million, up 56.3% from the prior year.
- Common Equity was $279.7 million for Q4 2025 at GH Research, up from $179.0 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $279.7 million in Q4 2025 to a low of $179.0 million in Q4 2024.
- Historically, Common Equity has averaged $240.9 million across 5 years, with a median of $249.8 million in 2022.
- The sharpest annual moves came in 2021 and 2024: Common Equity soared 4791.9% in 2021, then decreased 18.28% in 2024.
- A 5-year view of Common Equity shows it stood at $277.2 million in 2021, then dropped by 9.87% to $249.8 million in 2022, then declined by 12.35% to $219.0 million in 2023, then dropped by 18.28% to $179.0 million in 2024, then surged by 56.3% to $279.7 million in 2025.
- The last three Common Equity figures came in at $279.7 million (Q4 2025), $179.0 million (Q4 2024), and $219.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 13.21 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 279.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 279.70 Mn |
| Dec 31, 2024 | 178.95 Mn |
| Dec 31, 2023 | 218.97 Mn |
| Dec 31, 2022 | 249.82 Mn |
| Dec 31, 2021 | 277.18 Mn |
| Dec 31, 2020 | 5.67 Mn |